These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33027752)

  • 1. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
    Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
    Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
    Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
    Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
    Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
    Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
    Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma.
    Chen J; Wu F; Cao Y; Xing Y; Liu Q; Zhao Z
    PeerJ; 2023; 11():e15749. PubMed ID: 37547725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma.
    Li N; Chen J; Liu Q; Qu H; Yang X; Gao P; Wang Y; Gao H; Wang H; Zhao Z
    PeerJ; 2021; 9():e11901. PubMed ID: 34458019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
    Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
    BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
    Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
    Li J; Sheng C; Li W; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
    Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
    BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
    Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
    BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.